Skip to main content
. 2021 Jan 11;11:584533. doi: 10.3389/fphar.2020.584533

Figure 1.

Figure 1

Schematic representation of different molecular targets of cannabidiol (CBD) and their involvement on the mechanisms of hypoxic-ischemic brain injury (HIBI). Dot-lined boxes indicate which ones have been studied in preclinical models of neonatal HIBI.